Post-approval studies (Phase 4)Study completedNCT01042158
What this trial is testing
A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis
Who this might be right for
Pulmonary Arterial HypertensionSystemic SclerosisScleroderma Spectrum of Diseases+2 more
Johns Hopkins University 25